Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 4.31 USD 5.64% Market Closed
Market Cap: 300.2m USD

Wall Street
Price Targets

PHAT Price Targets Summary
Phathom Pharmaceuticals Inc

Wall Street analysts forecast PHAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHAT is 18.62 USD with a low forecast of 10.1 USD and a high forecast of 29.4 USD.

Lowest
Price Target
10.1 USD
134% Upside
Average
Price Target
18.62 USD
332% Upside
Highest
Price Target
29.4 USD
582% Upside
Phathom Pharmaceuticals Inc Competitors:
Price Targets
CORT
Corcept Therapeutics Inc
82% Upside
RAPP
Rapport Therapeutics Inc
320% Upside
NOVN
Novartis AG
10% Upside
867
China Medical System Holdings Ltd
3% Upside
AETHER
Aether Industries Ltd
46% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
19% Downside
DPHARMA
Duopharma Biotech Bhd
8% Upside
SANOFI
Sanofi India Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Phathom Pharmaceuticals Inc

The compound annual growth rate of Phathom Pharmaceuticals Inc's revenue for the next 3 years is 116%.

N/A
Past Growth
116%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Phathom Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Phathom Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHAT's stock price target?
Price Target
18.62 USD

According to Wall Street analysts, the average 1-year price target for PHAT is 18.62 USD with a low forecast of 10.1 USD and a high forecast of 29.4 USD.

What is Phathom Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
116%

The compound annual growth rate of Phathom Pharmaceuticals Inc's revenue for the next 3 years is 116%.

Back to Top